Similar articles

• In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus species.

  Afeltra J, Meis JF, Vitale RG, Mouton JW, Verweij PE; Eurofung Network. Afeltra J, et al. Antimicrob Agents Chemother. 2002 Jun;46(6):2029-31. doi: 10.1128/AAC.46.6.2029-2031.2002. Antimicrob Agents Chemother. 2002. PMID: 12019133 Free PMC article.
• In vitro antimicrobial activity of aromatic diamidines and diimidazolines related to pentamidine.

  Donkor IO, Clark AM. Donkor IO, et al. Eur J Med Chem. 1999 Jul-Aug;34(7-8):639-43. doi: 10.1016/s0223-5234(00)80032-x. Eur J Med Chem. 1999. PMID: 11278048
• Reasons for failure of prophylaxis for Pneumocystis carinii pneumonia.

  Edge MD, Rimland D. Edge MD, et al. AIDS. 1999 May 28;13(8):991-2. doi: 10.1097/00002030-199905280-00017. AIDS. 1999. PMID: 10371182 No abstract available.
• Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus.

  Pasqualotto AC. Pasqualotto AC. Med Mycol. 2009;47 Suppl 1:S261-70. doi: 10.1080/13693780802247702. Epub 2008 Jul 24. Med Mycol. 2009. PMID: 18654921 Review.
• Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.

  Korraa H, Saadeh C. Korraa H, et al. South Med J. 1996 Mar;89(3):272-7. doi: 10.1097/00007611-199603000-00003. South Med J. 1996. PMID: 8604455 Review.